top of page

In Conversation with Balderton: Reinventing Health Monitoring with SAVA

  • Writer: Sava
    Sava
  • Apr 14
  • 1 min read

What if real-time health monitoring didn’t require bulky devices, invasive tests, or sky-high costs?


At SAVA, that’s not a distant dream - it’s our reality in the making.


In this interview with Balderton, SAVA's Co-founder Renato Circi shares the vision, science, and startup grit behind SAVA’s journey to redefine biosensing technology. A conversation that goes well beyond the tech - touching on why most wearables fall short, the mindset needed to raise capital, and the lessons learned from the early journey from Imperial College to startup life.


 




Sava logo

117 CHARTERHOUSE STREET,

LONDON, EC1M 6AA, U.K

SAVA's biosensor is currently being investigated as an experimental device. The performance attributes of this sensor have not yet been fully determined and it has not received approval from the UK Medicine and Healthcare products Regulatory Agency or the U.S Food and Drug Administration (FDA). The availability of this device will depend on obtaining the necessary clearance or approval in the future. 

  • X
  • LinkedIn
bottom of page